Edgewise Therapeutics, Inc. EWTX Return on equity

Return on equity at other companies

Bristol-Myers SquibbBMY

46.7%+17.8pp

Sarepta Therapeutics, Inc.SRPT

-9.3%+2,662pp

Dyne Therapeutics, Inc.DYN

-58.9%-4.4pp

Solid Biosciences Inc.SLDB

-65.5%-2.5pp

Capricor TherapeuticsCAPR

-56.4%-11.3pp

Scholar RockSRRK

-167.8%-4.1pp

FAQ

What is Edgewise Therapeutics, Inc.'s return on equity?

Edgewise Therapeutics, Inc. (EWTX) reported return on equity of -38.1% in Q1 2026.

How has Edgewise Therapeutics, Inc.'s return on equity changed year-over-year?

Edgewise Therapeutics, Inc.'s return on equity decreased by 25.9% year-over-year, from -30.3% to -38.1%.

What is the long-term trend for Edgewise Therapeutics, Inc.'s return on equity?

Over 3 years (2022 to 2025), Edgewise Therapeutics, Inc.'s return on equity has grown at a 16.2% compound annual growth rate (CAGR), from -21.8% to -34.2%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.